Objective: The study was aimed to observe the changes in mean platelet volume in patients with sudden hearing loss, taking the close relationship of vascular reasons and sudden hearing loss into account.

Materials And Methods: Patients who were admitted and treated with sudden hearing loss in the study. The control group was made up of healthy people. The hemoglobin values, mean platelet volumes, platelet counts of the groups were recorded.

Results: Forty sixth patients in the sudden hearing loss group and 45 patients in the control group were evaluated. No statistically significant difference between the two groups regarding mean platelet volume values and platelet counts were found. There was also no significant difference between the high mean platelet volumes and hearing loss levels.

Conclusions: We think it would be beneficial to examine the mean platelet volume values in further studies with more patient series on patients with sudden hearing loss.

Download full-text PDF

Source
http://dx.doi.org/10.7471/CT.2014.1679DOI Listing

Publication Analysis

Top Keywords

hearing loss
28
sudden hearing
24
platelet volume
16
patients sudden
16
platelet
8
volume patients
8
control group
8
values platelet
8
platelet volumes
8
platelet counts
8

Similar Publications

The Canadian Association of Radiologists (CAR) Central Nervous System Expert Panel is made up of physicians from the disciplines of radiology, emergency medicine, neurosurgery, and neurology, a patient advisor, and an epidemiologist/guideline methodologist. After developing a list of 24 clinical/diagnostic scenarios, a rapid scoping review was undertaken to identify systematically produced referral guidelines that provide recommendations for one or more of these clinical/diagnostic scenarios. Recommendations from 55 guidelines and contextualization criteria in the Grading of Recommendations, Assessment, Development, and Evaluations (GRADE) for guidelines framework were used to develop 51 recommendation statements across the 24 scenarios.

View Article and Find Full Text PDF

Objective: This study aims to assess the relationship between modifiable dementia risk factors and both dementia and cognitive decline.

Methods: Data were obtained from the Health and Retirement Study (HRS) [2008-2020], the China Health and Retirement Longitudinal Study (CHARLS) [2011-2020], and the English Longitudinal Study of Ageing (ELSA) [2010-2020]. After adjusting for confounding factors, multivariable logistic regression was utilized to analyze the relationship between modifiable dementia risk factors and dementia, while multivariable linear regression was employed to examine the relationship between these risk factors and cognitive decline.

View Article and Find Full Text PDF

Introduction: Cisplatin is extensively employed in the treatment of multiple solid malignant tumors. Nevertheless, side effects such as cisplatin-induced ototoxicity (CIO) pose obstacles to tumor therapy.The important natural product chiisanoside from has abundant activity against CIO.

View Article and Find Full Text PDF

 Many patients with neurofibromatosis type 2 (NF2) suffer from sensorineural hearing loss, and associated cochlear nerve compromise in NF2 patients makes auditory brainstem implant (ABI) an attractive treatment option. The long-term outcomes and benefits of the device are still being explored.  A retrospective review was conducted for 11 ABI recipients at a single-institution tertiary center between November 2017 and August 2022.

View Article and Find Full Text PDF

Cochlear implantation and cognitive function in the older adult population: current state of the art and future perspectives.

Braz J Otorhinolaryngol

January 2025

Antwerp University Hospital (UZA), Department of Otorhinolaryngology, Head and Neck Surgery, Edegem, Belgium; University of Antwerp, Faculty of Medicine and Health Sciences, Department of Translational Neurosciences, Resonant Labs Antwerp, Antwerp, Belgium.

Objectives: Hearing loss is associated with increased cognitive decline and incident dementia in older adults. Given the rapidly rising incidence of dementia, management of modifiable risk factors such as hearing loss, is essential to mitigate the impact on the individual and society in general. In this narrative review, we discuss the current state-of-art with respect to studying cognitive function before and after cochlear implantation in the elderly population.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!